SELLAS Life Sciences Group Total Non Current Liabilities | SLS

Annual Total Non Current Liabilities SELLAS Life Sciences Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
-	-	-	-	-	825 K	5.23 M	5.7 M	6.89 M	6.76 M	11.6 M	16.2 M	19.6 M	11.3 M	9.65 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
19.6 M	825 K	9.38 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Aclaris Therapeutics ACRS	5.95 M	$ 5.32	0.09 %	$ 652 M	USA
ADC Therapeutics SA ADCT	341 M	$ 1.05	0.46 %	$ 133 M	Schweiz
Agenus AGEN	264 M	$ 7.21	0.7 %	$ 214 M	USA
Фармсинтез LIFE	13.2 M	-	-	-	Russia
Akebia Therapeutics AKBA	168 M	$ 0.92	1.64 %	$ 237 M	USA
Alector ALEC	165 M	$ 1.93	0.81 %	$ 199 M	USA
Amryt Pharma plc AMYT	302 M	-	-	$ 621 M	Britain
Aligos Therapeutics ALGS	15 M	$ 5.05	1.2 %	$ 49.9 M	USA
Alkermes plc ALKS	329 M	$ 46.07	0.09 %	$ 7.59 B	Irlanda
Allogene Therapeutics ALLO	55.7 M	$ 1.69	0.58 %	$ 373 M	USA
Alnylam Pharmaceuticals ALNY	604 M	$ 239.36	0.46 %	$ 31.4 B	USA
Altimmune ALT	5.33 M	$ 3.24	0.31 %	$ 285 M	USA
ALX Oncology Holdings ALXO	5.97 M	$ 1.76	0.53 %	$ 94.4 M	USA
Evelo Biosciences EVLO	40.3 M	-	-14.46 %	$ 27.9 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 23.95	1.31 %	$ 1.12 B	USA
AnaptysBio ANAB	654 K	$ 54.31	0.15 %	$ 1.56 B	USA
Anika Therapeutics ANIK	26.1 M	$ 20.84	0.24 %	$ 299 M	USA
ANI Pharmaceuticals ANIP	182 M	$ 73.59	2.05 %	$ 1.48 B	USA
Aptevo Therapeutics APVO	5 M	$ 1.72	0.58 %	$ 543 K	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.82	0.21 %	$ 515 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 15.6	0.25 %	$ 427 M	Israel
Armata Pharmaceuticals ARMP	14 M	$ 4.07	2.21 %	$ 147 M	USA
Assembly Biosciences ASMB	18.2 M	$ 25.48	0.54 %	$ 286 M	USA
Actinium Pharmaceuticals ATNM	682 K	$ 1.24	0.79 %	$ 38.7 M	USA
AbbVie ABBV	81.7 B	$ 262.51	0.01 %	$ 464 B	USA
Atara Biotherapeutics ATRA	15.4 M	$ 10.11	7.1 %	$ 127 M	USA
Aurinia Pharmaceuticals AUPH	41.9 M	$ 16.96	5.15 %	$ 2.28 B	Canada
Autolus Therapeutics plc AUTL	50.6 M	$ 1.87	0.53 %	$ 498 M	Britain
Atea Pharmaceuticals AVIR	69.2 M	$ 5.15	1.24 %	$ 420 M	USA
Axon Enterprise AXON	107 M	$ 468.42	5.96 %	$ 36.6 B	USA
Axsome Therapeutics AXSM	48.9 M	$ 211.97	3.87 %	$ 10.5 B	USA
Aytu BioScience AYTU	42.1 M	$ 1.97	0.5 %	$ 12.4 M	USA
BridgeBio Pharma BBIO	97.6 M	$ 68.3	0.1 %	$ 13.1 B	USA
Bicycle Therapeutics plc BCYC	8.18 M	$ 3.64	0.68 %	$ 252 M	Britain
Black Diamond Therapeutics BDTX	7.69 M	$ 1.94	1.02 %	$ 110 M	USA
Beam Therapeutics BEAM	26 M	$ 23.1	0.15 %	$ 2.28 B	USA
Biogen BIIB	9.03 B	$ 216.01	0.42 %	$ 31.6 B	USA
BioLineRx Ltd. BLRX	5.44 M	$ 2.48	0.79 %	$ 6.11 B	Israel
AbCellera Biologics ABCL	326 M	$ 11.67	2.28 %	$ 3.49 B	Canada
Benitec Biopharma BNTC	213 K	$ 11.04	0.9 %	$ 514 M	USA
Clovis Oncology CLVS	579 M	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	196 K	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	17.9 M	-	-	$ 401 M	USA
Cabaletta Bio CABA	43.9 M	$ 2.49	0.39 %	$ 250 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.24	0.89 %	$ 3.69 M	Israel
Catalyst Biosciences CBIO	981 K	$ 17.18	1.7 %	$ 1.53 B	USA
C4 Therapeutics CCCC	75.5 M	$ 3.45	0.58 %	$ 286 M	USA